The overhaul of GLP-1 marketing; The MAHA split ahead of the midterms; Roche and the future of AI in medicine.
Amid a wave of industry consolidation, French holding company Havas occupies a unique position. While Publicis, Omnicom and ...
Skyrizi remained the most-seen pharma brand on national TV, while Colgate surged to the top of Tubular Labs’ monthly YouTube ...
FDA approves Lilly’s weekly insulin shot; Study finds tobacco industry spammed FDA comments opposing menthol cigarette ban; ...
In this episode, we explore how healthcare organizations can work with patient, consumer and HCP creators to build influence ...
The run-up to the midterm elections is turning into a food fight — literally. The summer was marred by a massive foodborne ...
The FDA approved Ultragenyx Pharmaceutical’s Fayuvi (rebisufligene etisparvovec-hopf), the first treatment for children with ...
For Hispanic Heritage Month, marketing leaders from Cologuard and MetroPlusHealth explain why culturally relevant healthcare ...
The multiyear deal embeds real-time pricing into Epocrates' drug content. Executives call the launch a baseline and pitch it ...
Trust in the pharma industry has been steadily declining among consumers, regardless of political affiliation. A 2023 study ...
Brand awareness has long served as a measure of marketing success. But as AI increasingly shapes how people discover, understand and evaluate healthcare brands, awareness no longer tells the full ...
The drugmaker designed “Because Ibsrela Can” with clear, static safety visuals after studying the agency’s recent objections ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results